|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,760.00 KRW | +1.21% |
|
+5.17% | -45.35% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Quotes 5-day view: Genome & Company
End-of-day quote Korea S.E.| 2026-06-29 | 2026-06-30 | 2026-07-01 | 2026-07-02 | 2026-07-03 | |
|---|---|---|---|---|---|
| Last | ₩3,835.00 | ₩3,860.00 | ₩4,110.00 | ₩3,715.00 | ₩3,760.00 |
| Volume | 693,499 | 428,650 | 331,185 | 258,727 | 395,557 |
| Change | +7.27% | +0.65% | +6.48% | -9.61% | +1.21% |
| Opening | ₩3,520.00 | ₩3,835.00 | ₩3,860.00 | ₩4,095.00 | ₩3,825.00 |
| High | ₩3,975.00 | ₩4,100.00 | ₩4,175.00 | ₩4,100.00 | ₩3,840.00 |
| Low | ₩3,520.00 | ₩3,620.00 | ₩3,660.00 | ₩3,690.00 | ₩3,520.00 |
Performance
| 1 day | +1.21% | ||
| 1 week | +5.17% | ||
| Current month | -2.59% | ||
| 1 month | -30.63% | ||
| 3 months | -48.14% | ||
| 6 months | -47.92% | ||
| Current year | -45.35% | ||
| 1 year | +23.08% | ||
| 3 years | -55.40% | ||
| 5 years | -81.45% |
Volumes
marketsDaily volume
395,557
Avg. Volume 20 sessions
514,163
Avg. Volume 20 sessions KRW
1,933,252,880
Avg. Volume 20 sessions USD
1,264,347.38
Record volume 1
30,576,260
Record volume 2
14,495,024
Record volume 3
7,918,904
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (KRW)
169,869,855,959
Market Cap (USD)
110,981,802
Net sales ()
24,586,847,080
Net sales (USD)
16,063,430
Free-Float
82.77 %
Free-Float capitalization (KRW)
140,600,229,842
Free-Float capitalization (USD)
91,858,952
Average Daily Capital Traded
1.14%
Indicators
Moving average 5 days
3,856
Moving average 20 days
4,741
Moving average 50 days
5,719.8
Moving average 100 days
6,683
Price spread / (MMA5)
+2.55%
Price spread / (MMA20)
+26.09%
Price spread / (MMA50)
+52.12%
Price spread / (MMA100)
+77.74%
RSI 9 days
32.87
RSI 14 days
34.4
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.21% | +5.17% | +23.08% | -55.40% | 111M | |
| +1.70% | +7.41% | +2.50% | +8.18% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +604.02% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.27% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +55.45% | 33.09B | |
| +3.96% | +10.67% | +8.30% | +37.95% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +135.37% | 15.92B | |
| +0.32% | +0.58% | +14.00% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +93.88% | 13.52B | |
| Average | +2.08% | +5.05% | +73.17% | +99.14% | 24.58B | |
| Weighted average by Cap. | +2.07% | +6.53% | +90.17% | +135.77% |
Historical Quotes: Genome & Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 3,520 |  | 4,175 |
| 1 month | 3,510 | | 6,130 |
| Current year | 3,510 | | 10,180 |
| 1 year | 2,440 | | 10,180 |
| 3 years | 2,170 | | 10,180 |
| 5 years | 2,170 | | 28,800 |
| 10 years | 2,170 | | 47,500 |
Monthly variations
Annual variations
| 2026 | -45.35% | ||
| 2025 | +150.18% | ||
| 2024 | -55.96% | ||
| 2023 | -28.42% | ||
| 2022 | -49.71% | ||
| 2021 | -56.35% | ||
| 2020 | +102.29% | ||
| 2019 | +219.51% | ||
| 2018 | +31.83% |
- Stock Market
- Stocks
- A314130 Stock
- Quotes Genome & Company
Select your edition
All financial news and data tailored to specific country editions
